Temporally Controlled Onset of Dilated Cardiomyopathy Through Disruption of the SRF Gene in Adult Heart
Author(s) -
Ara Parlakian,
Claude Charvet,
Brigitte Escoubet,
Mathias Mericskay,
Jeffery D. Molkentin,
Guillaume GaryBobo,
León J. De Windt,
MarieAline Ludosky,
Denise Paulin,
Dominique Daegelen,
David Tuil,
Zhenlin Li
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.105.533778
Subject(s) - serum response factor , medicine , heart failure , dilated cardiomyopathy , cardiomyopathy , cardiac function curve , contractility , myocyte , endocrinology , gene expression , biology , gene , biochemistry
Serum response factor (SRF) is a cardiac transcription factor involved in cell growth and differentiation. We have shown, using the Cre/loxP system, that cardiac-specific disruption of SRF gene in the embryonic heart results in lethal cardiac defects. The role of SRF in adult heart is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom